News & Updates

Show Multimedia Only

COVID-19 ups new-onset respiratory T2ID risk

20 Apr 2026 by

A study shows an association between COVID-19 infection and an elevated risk of new-onset respiratory type 2 inflammatory diseases (T2IDs), while vaccination remains protective against such diseases.

20 Apr 2026

Fluvoxamine improves fatigue, QoL in long COVID patients

19 Apr 2026 by

Patients with long COVID may derive benefits from treatment with fluvoxamine, which has been shown to reduce fatigue and improve quality of life (QoL) in a study. The use of metformin, on the other hand, shows no significant advantage.

19 Apr 2026

Post-exposure PIP comparable to PrEP for low-risk HIV, but more affordable

17 Apr 2026 by

Post-exposure prophylaxis-in-pocket (PIP) appears as effective as pre-exposure prophylaxis (PrEP) in improving quality of life (QoL) of individuals at low risk for HIV but may be a less costly option, according to a matched-control study presented at CROI 2026.

17 Apr 2026

Real-world evidence positions nirsevimab ahead in infant RSV prevention

14 Apr 2026

Respiratory syncytial virus (RSV) remains a leading cause of hospitalisation and severe lower respiratory tract infection (LRTI) in infants worldwide. [Lancet 2022;399:2047-2064; Lancet 2017;390:946-958] In recent years, two immunoprophylactic strategies have become available to protect infants, namely maternal immunisation with the RSV prefusion F (RSVpreF) vaccine and passive immunisation of infants with the long-acting monoclonal antibody nirsevimab.

14 Apr 2026

Genes affect response to COVID-19 vax, standard vaccination approach appropriate for SAD patients

11 Apr 2026 by

Genetic markers, both in and outside the immune system, influence an individual’s response to the SARS-CoV-2 vaccine, and these effects are similar in patients with or without systemic autoimmune diseases (SADs), reports a study.

11 Apr 2026

CDI linked to adverse outcomes among hospitalized patients with cancer

09 Apr 2026

For hospitalized cancer patients, contracting Clostridioides difficile infection (CDI) contributes to a substantial increase in mortality and healthcare resource use, according to a cross-sectional study.

09 Apr 2026

CKD patients more prone to tuberculosis

30 Mar 2026 by

Patients with stage 5 chronic kidney disease (CKD5) are at greater risk of developing tuberculosis (TB) than the general population, especially if they are male or receiving dialysis, suggests a Singapore study.

30 Mar 2026

Antibiotics, low-yield investigations for recurrent UTI prevail in real-world practice

29 Mar 2026 by

Recurrent urinary tract infection (UTI) care in primary and secondary care settings appears to be characterized by low guideline adherence, with a substantial number of women still being treated with antibiotics and subjected to low-yield investigations, according to a study.

29 Mar 2026

Severe infections added to list of obesity-related comorbidities

24 Mar 2026 by

Adults with obesity are at increased risk of infection-related hospitalizations and mortality, with a 10th of infection-related deaths estimated to be attributable to obesity, according to a study.

24 Mar 2026

GERD, complications up NTM infection risk

23 Mar 2026

Gastroesophageal reflux disease (GERD) and its complications appear to increase the risk of nontuberculous mycobacterium (NTM) infection, suggests a study.